NBP Insider Transactions
5 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 1–5; provenance stays internal.
NBP insiders transaction timeline
PurchaseSale
| Insider profile | Role | Date | Transaction | Shares | Price |
|---|---|---|---|---|---|
| Xu Cong Claire | SVP, Clinical Development | 2026-07-06 | Sale | 4,485 | $0.89 |
| Dennis Phillip Andrew | Chief Medical Officer | 2026-06-18 | Sale | 8,494.0 | $0.66 |
| Xu Cong Claire | SVP, Clinical Development | 2026-06-01 | Sale | 3,494.0 | $3.94 |
| Cao Sean Wuxiong | See Remarks | 2026-05-14 | Sale | 21,399.0 | $1.99 |
| Hagler Mark Arnold | See Remarks | 2026-04-24 | Purchase | 230,000.0 | $2.51 |